Literature DB >> 11156879

Midwall mechanics are improved after regression of hypertensive left ventricular hypertrophy and normalization of chamber geometry.

S Perlini1, M L Muiesan, C Cuspidi, L Sampieri, B Trimarco, G P Aurigemma, E Agabiti-Rosei, G Mancia.   

Abstract

BACKGROUND: It is still unclear whether substantial regression of hypertensive left ventricular hypertrophy (LVH) and normalization of chamber geometry are associated with improved left ventricular (LV) myocardial function. METHODS AND
RESULTS: Midwall mechanics were evaluated in 152 patients undergoing 1 year of effective antihypertensive treatment. Two-dimensionally directed M-mode echocardiography was performed as follows: (1) after a 4-week placebo "run-in" period, (2) after 1 year of treatment with 20 mg/d lisinopril (alone or associated with 12.5 to 25 mg/d hydrochlorothiazide), and (3) after a final 1-month placebo period to allow blood pressure (24-hour average ambulatory monitoring) to return to pretreatment levels. Treatment-induced reductions in blood pressure (from 149+/-16/95+/-11 to 131+/-12/83+/-10 mm Hg, P:<0.05) and circumferential end-systolic wall stress (from 84+/-22 to 72+/-19 g/cm(2), P:<0.05) were associated with a marked reduction in LV mass index (from 159+/-30 to 133+/-26 g/m(2), P:<0.05). LVH regression was accompanied by an increase in midwall fractional shortening (from 19.7+/-2.7% to 20.9+/-2.7%, P:<0.05) and by a decrease in relative wall thickness (from 48.2+/-7.7% to 44.1+/-6.7%, P:<0.05). The improvement in midwall function associated with afterload reduction and substantial LVH regression persisted after antihypertensive therapy withdrawal and restoration of the hypertensive state. Despite a significant increase in end-systolic wall stress, further LV chamber remodeling did not occur. The preservation of relative wall thickness was associated with a persistent improvement in midwall systolic function.
CONCLUSIONS: Regression of concentric LVH is associated with an improvement of midwall systolic function, which is more dependent on the normalization of LV geometry than on the reduction in LV systolic stress.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11156879     DOI: 10.1161/01.cir.103.5.678

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

1.  Left ventricular layer function in hypertension assessed by myocardial strain rate using novel one-beat real-time three-dimensional speckle tracking echocardiography with high volume rates.

Authors:  Maki Saeki; Noriaki Sato; Masanori Kawasaki; Ryuhei Tanaka; Maki Nagaya; Takatomo Watanabe; Koji Ono; Toshiyuki Noda; Michael R Zile; Shinya Minatoguchi
Journal:  Hypertens Res       Date:  2015-04-02       Impact factor: 3.872

Review 2.  Management of hypertension in patients with left ventricular hypertrophy.

Authors:  Cesare Cuspidi; Carla Sala; Alberto Zanchetti
Journal:  Curr Hypertens Rep       Date:  2007-12       Impact factor: 5.369

Review 3.  Hypertension, left ventricular hypertrophy, and sudden death.

Authors:  Lwin Lwin Tin; D Gareth Beevers; Gregory Y H Lip
Journal:  Curr Cardiol Rep       Date:  2002-11       Impact factor: 2.931

4.  Spectrum of cardiac abnormalities associated with long QT in stroke survivors.

Authors:  K Y K Wong; S McSwiggan; N S J Kennedy; S Y S Wong; A Gavin; R S MacWalter; A D Struthers
Journal:  Heart       Date:  2005-10       Impact factor: 5.994

5.  Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction.

Authors:  Barry A Borlaug; Carolyn S P Lam; Véronique L Roger; Richard J Rodeheffer; Margaret M Redfield
Journal:  J Am Coll Cardiol       Date:  2009-07-28       Impact factor: 24.094

6.  Prevalence and prognostic value of conduction disturbances at the time of diagnosis of cardiac AL amyloidosis.

Authors:  Michele Boldrini; Francesco Salinaro; Roberta Mussinelli; Ambra Raimondi; Alessio Alogna; Francesco Musca; Giovanni Palladini; Giampaolo Merlini; Stefano Perlini
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-01-20       Impact factor: 1.468

7.  Rationale and design of the SMART Heart study: A prediction model for left ventricular hypertrophy in hypertension.

Authors:  M F L Meijs; M L Bots; E-J A Vonken; M-J M Cramer; P G Melman; B K Velthuis; Y van der Graaf; W P Th M Mali; P A Doevendans
Journal:  Neth Heart J       Date:  2007       Impact factor: 2.380

8.  Relationship between early diastolic strain rate imaging and left ventricular geometric patterns in hypertensive patients.

Authors:  Hyungseop Kim; Hyun-Ok Cho; Yun-Kyeong Cho; Chang-Wook Nam; Seong-Wook Han; Seung-Ho Hur; Kee-Sik Kim; Yoon-Nyun Kim; Kwon-Bae Kim
Journal:  Heart Vessels       Date:  2008-07-23       Impact factor: 2.037

Review 9.  Angiotensin II receptor blockers and cardiovascular protection: focus on left ventricular hypertrophy regression and atrial fibrillation prevention.

Authors:  Cesare Cuspidi; Francesca Negri; Alberto Zanchetti
Journal:  Vasc Health Risk Manag       Date:  2008
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.